BETA DRUGS
Sector : Pharmaceuticals and health care | Smallcap | NSE
Here's the live share price of Beta Drugs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0₹ 0
As on Nov 3, 2025, 10:17 AM IST
Beta Drugs Price Performance
Today's LowToday's High
₹0.00₹0.00
₹1,855.00
52 Weeks' Low52 Weeks' High
₹1,428.95₹2,214.35
₹1,855.00
Open Price
₹0.00
Prev. Close
₹1,855.00
Over the last 5 years, the share price of Beta Drugs has gained 76.29% CAGR. Over the past year, the corresponding return has been -1.19%.
Beta Drugs’s current P/E of 44.14x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Beta Drugs Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Beta Drugs | 3.06 | 2.15 | 7.23 | 9.44 | -1.19 | 39.31 | 76.29 |
| Sun Pharmaceutical Industries | -0.65 | 3.16 | 3.57 | -7.73 | -9.17 | 17.65 | 29.17 |
| Divi's Laboratories | 2.96 | 18.88 | 6.70 | 11.21 | 14.98 | 20.95 | 17.36 |
| Cipla | -5.21 | -0.73 | -0.06 | -1.55 | -3.70 | 8.58 | 14.86 |
| Torrent Pharmaceuticals | -0.27 | 0.13 | -2.90 | 9.72 | 11.43 | 28.43 | 22.90 |
| Dr. Reddy's Laboratories | -7.33 | -4.43 | -2.55 | 0.56 | -5.57 | 9.46 | 4.13 |
| Mankind Pharma | -2.46 | -2.75 | -7.55 | -0.56 | -11.50 | 18.60 | 10.78 |
| Zydus Lifesciences | -3.22 | -1.88 | 2.48 | 9.82 | -3.13 | 30.96 | 18.82 |
| Lupin | 2.70 | 0.10 | 6.21 | -3.59 | -9.76 | 40.88 | 16.80 |
| Aurobindo Pharma | 5.07 | 4.97 | 5.58 | -5.93 | -18.61 | 27.52 | 8.42 |
| Alkem Laboratories | -0.38 | 1.18 | 12.76 | 8.83 | -4.84 | 19.63 | 15.74 |
| Abbott India | -2.79 | -2.66 | -13.39 | -5.31 | -0.68 | 13.91 | 13.40 |
| Glenmark Pharmaceuticals | 4.29 | -3.18 | -8.26 | 37.96 | 12.22 | 66.17 | 32.00 |
| Laurus Labs | 4.15 | 10.64 | 13.59 | 55.47 | 93.04 | 27.01 | 26.25 |
| Biocon | 4.17 | 8.10 | -2.24 | 17.43 | 17.84 | 11.48 | -1.51 |
| GlaxoSmithKline Pharmaceuticals | -4.26 | -2.10 | -10.08 | -7.44 | -3.38 | 24.19 | 13.38 |
| Anthem Biosciences | -1.68 | -8.18 | -4.14 | -3.08 | -3.08 | -1.04 | -0.62 |
| Ipca Laboratories | 1.14 | -3.32 | -11.52 | -6.89 | -20.15 | 11.54 | 2.20 |
| Gland Pharma | 0.08 | -1.95 | -1.80 | 38.43 | 18.01 | 2.84 | 1.32 |
| Ajanta Pharma | 2.42 | 3.11 | -8.25 | -4.35 | -19.87 | 23.17 | 18.67 |
Over the last one year, Beta Drugs has declined 1.19% compared to peers like Sun Pharmaceutical Industries (-9.17%), Divi's Laboratories (14.98%), Cipla (-3.70%). From a 5 year perspective, Beta Drugs has outperformed peers relative to Sun Pharmaceutical Industries (29.17%) and Divi's Laboratories (17.36%).
Beta Drugs Financials
Beta Drugs Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 1,863.07 | 1,854.53 |
| 10 | 1,835.33 | 1,835.3 |
| 20 | 1,792.31 | 1,817.89 |
| 50 | 1,833.33 | 1,813.34 |
| 100 | 1,799.6 | 1,807.77 |
| 200 | 1,787.45 | 1,772.83 |
Beta Drugs Share Holding Pattern
In the latest quarter, Beta Drugs remained same as its previous close in promoter holding, while DII stake increased to 0.29%, FII holding unchanged at 0.90%, and public shareholding moved down to 32.07% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Beta Drugs Corporate Actions
There's no recent Announcement information to show for the company. You may visit the Beta Drugs fact sheet for more information
About Beta Drugs
Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company's Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 220.20 Cr. and Equity Capital is Rs. 10.09 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressVillage Nandpur, Baddi Himachal Pradesh 174101
- Contact
Management
- Mr. Rahul BatraChairperson & Managing Director
- Mr. Varun BatraJoint Managing Director
- Mrs. Seema ChopraWhole Time Director
- Mr. Balwant SinghWhole Time Director
- Mr. Manmohan KhannaIndependent Director
- Mr. Ashutosh ShuklaWhole Time Director
- Mr. Rohit PartiIndependent Director
FAQs on Beta Drugs Share Price
What is the share price of Beta Drugs?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Beta Drugs is ₹1,855.00 as on Nov 03, 2025.
What kind of stock is Beta Drugs?
The Beta Drugs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the NSE.
What is the Market Cap of Beta Drugs?
The market cap of Beta Drugs is ₹1,872.54 Cr as on Nov 03, 2025.
What are today's High and Low prices of Beta Drugs?
Today’s highest and lowest price of Beta Drugs are ₹0.00 and ₹0.00.
What are the 52 Week High and 52 Week Low of Beta Drugs?
The 52-week high/low is the highest and lowest price at which Beta Drugs stock has traded in the past 52-week or nearly a year. The 52-week high of Beta Drugs is ₹2,214.35 and 52-week low of Beta Drugs is ₹1,428.95 as on Nov 03, 2025.
How has the Beta Drugs performed historically in terms of returns?
The Beta Drugs has shown returns of 0.0% over the past day, 2.15% for the past month, 7.23% over 3 months, -1.19% over 1 year, 39.31% across 3 years, and 76.29% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Beta Drugs?
P/E ratio of and PB ratio of Beta Drugs are 44.14 and 10.35 on Nov 03, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse